In support of this hypothesis, previous work has demonstrated a progression from luminal to cytoplasmic EBP50 expression occurs across normal to ductal carcinoma in-situ to invasive and metastatic breast cancer tissues[25]. This evidence concerns the gene NHERF1 and ductal breast carcinoma in situ.